|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Improved results with mitral valve repair using new surgical techniques显示文摘 | FUCCI C SANDRELLI L PARDINI A | 1995 | EurJ Cardiothorac Surg1995，9，11： | 1 |
| 2 | MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorec- tal caneer显示文摘 | Colangelo T Fucci A Votino C | 2013 | Neoplasia2013，15，9： | 1 |
| 3 | MicroRNA - 130b promotes tumor development and is associated with poor prognosis in colorectal cancer显示文摘 | Colangelo T Fucci A Votino C | 2013 | Neoplasia ( New York NY)2013，15，9： | 1 |
| 4 | Improved results with mitral valve repair using new surgical techniques 显示文摘 | Fucci C Sandrelli L Pardini A | 1995 | Eur J Cardiothorac Surg1995，9，11： | 1 |
| 5 | MicroRNA-130bpromotes tumor development and is associated with poorprognosis in colorectal cancer 显示文摘 | Colangelo T Fucci A Votino C | 2013 | Neoplasia2013，15，9： | 1 |
| 6 | Improved results with mitral valve repair using new surgical techniques显示文摘 | Fucci C Sandrelli L Pardini A | 1995 | Eur J Cardiothorac Surg1995，9，11： | 1 |
| 7 | Improved results with mitral valve repair using new surgical techniques显示文摘 | SANDRELLI L PARDINIA | 1995 | Eur J cardiothorac surg1995，9，11： | 1 |
| 8 | Mitral valve periprosthetic leakage:anatomical obser vations in 135 patients from a multicentre study显示文摘 | De Cieco G Russo C Moreo A Beghi C Fucci C Gerometta P | 2006 | Eur J Cardiothorac Surg2006，30，： | 1 |
| 9 | Structural effects of an innovative surgical technique to repair heart valve defects显示文摘 | Dal Pan F Donzella G Fucci C | | 0，，12： | 1 |
| 10 | Improved results with mitral valve repair using new surgical techniques 显示文摘 | FUCCI C SANDRELLI L PARDINI A | 1995 | Eur J Cardiothorac Surg1995，9，11： | 1 |
| 11 | Improved results with mitral valve repair using new surgical techniques显示文摘 | Fucci C Sandrelli L Pardini A | 1995 | Eur J Cardionthorac Surg1995，9，11： | 1 |
| 12 | Improved results with mitral valve repair using new surgical techniques显示文摘 | Fucci C Sandrelli L Pardini A | 1995 | Eur J Cardiothorac Surg1995，9，： | 1 |
| 13 | Meplazumab in hospitalized adults with severe COVID-19(DEFLECT):a multicenter,seamless phase 2/3,randomized,third-party double-blind clinical trial显示文摘Meplazumab,a humanized CD147 antibody,has shown favourable safety and efficacy in our previous clinical studies.In DEFLECT(NCT04586153),167 patients with severe COVID-19 were enroled and randomized to receive three dosages of meplazumab and a placebo.Meplazumab at 0.12 mg/kg,compared to the placebo group,showed clinical benefits in significantly reducing mortality by 83.6%(2.4%vs.14.6%,p=0.0150),increasing the proportion of patients alive and discharged without supplemental oxygen(82.9%vs.70.7%,p=0.0337)and increasing the proportion of patients who achieved sustained clinical improvement(41.5%vs.31.7%).The response rate in the 0.2 mg/kg group was relatively increased by 16.0%compared with the placebo group(53.7%vs.46.3%).Meplazumab also reduced the viral loads and multiple cytokine levels.Compare with the placebo group,the 0.3 mg/kg significantly increased the virus negative rate by 40.6%(p=0.0363)and reduced IL-8 level(p=0.0460);the 0.2 mg/kg increased the negative conversion rate by 36.9%,and reduced IL-4(p=0.0365)and IL-8 levels(p=0.0484).In this study,the adverse events occurred at a comparable rate across the four groups,with no unexpected safety findings observed.In conclusion,meplazumab promoted COVID-19 convalescence and reduced mortality,viral load,and cytokine levels in severe COVID-19 population with good safety profile. | Huijie Bian Liang Chen Zhao-Hui Zheng Xiu-Xuan Sun Jie-Jie Geng Ruo Chen Ke Wang Xu Yang Shi-Rui Chen Si-Yu Chen Rong-Hua Xie Kui Zhang Jin-Lin Miao Jun-Feng Jia Hao Tang Shuang-Shuang Liu Hong-Wei Shi Yong Yang Xiao-Chun Chen Vinay Malhotra Nosheen Nasir Iffat Khanum Faisal Mahmood Saeed Hamid Claudio Marcel Berdun Stadnik Kengi Itinose Caroline Cândida Carvalho de Oliveira Cesar Dusilek Lucas Rivabem Adilson Joaquim Westheimer Cavalcante Suzara Souto Lopes Wladmir Faustino Saporito Fábio JoséConcilio Fucci Jesus Abraham Simon-Campos Ling Wang Lin-Na Liu Qing-Yi Wang Ding Wei Zheng Zhang Zhi-Nan Chen Ping Zhu | 2023 | Signal Transduction and Targeted Therapy2023，8，2： | 1 |
| 14 | Edge-to-edge mitral valve repair for isolated prolapse of the anterior leaflet caused by degene- rative disease显示文摘 | Fucci C Cicco GD Chiari E | 2007 | J Cardiovasc Med2007，8，5： | 1 |
| 15 | Neutrophil count in small-for-gestational age children:Contrasting effects of metformin and growth hormone therapy显示文摘 | Ibanez L Fucci A Valls C | 2005 | J Clin Endocrinol Metab2005，90，： | 1 |
| 16 | Evalua- tion of two methods for the use of diatoms in drown- ing cases显示文摘 | Fucci N Pascali VL Puccinelli C et 01 | 2015 | Forensic Sci Med Pathol2015，，： | 1 |
| 17 | The triple - orfiee repair: a new technique for the treatment of mitral regurgitation in severe Barlow disease显示文摘 | Fucci C Lorusso R Totaro P | 2004 | Ital Heart J2004，5，： | 1 |
| 18 | Edge-to-edge mitral valve repair for isolated prolapse of the anterior leaflet caused by degenerative disease 显示文摘 | Fucci C Cicco G D Chiari E | 2007 | J Cardiovasc Med ( Hagerstown)2007，8，5： | 1 |
| 19 | Improved results with mitral valve repair using new surgical techniques显示文摘 | Fucci C Sandrelli L Pardini A | | 0，，： | 1 |
| 20 | Improved results with mitral valve repair using new surgical techniques 显示文摘 | Fucci C Sandrelli L Pardini A | 1995 | Eur J Cardiothorac Surg1995，9，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员